{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:45:24Z","timestamp":1782711924445,"version":"3.54.5"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>Anatabine, a characteristic minor alkaloid derived from tobacco byproducts, exhibits unique structural analogy to nicotine but possesses a superior safety profile and lower addictive liability, rendering it a promising natural multi-target therapeutic candidate. Accumulating preclinical evidence has demonstrated that anatabine exerts neuroprotective, anti-inflammatory, and antioxidant effects mainly through modulating \u03b17\/\u03b14\u03b22 nicotinic acetylcholine receptors, suppressing NF-\u03baB\/STAT3 inflammatory signaling, and activating the Nrf2-mediated antioxidant pathway. It effectively ameliorates typical pathological alterations, including \u03b2-amyloid deposition, tau hyperphosphorylation, and microglial overactivation, thereby improving cognitive and behavioral deficits in neurodegenerative disease models. Additionally, anatabine displays broad pharmacological potentials in chronic inflammation, autoimmune thyroiditis, asthma, and hypertension. Differing from previous reviews that merely focused on single receptor regulation, the present work systematically summarizes the multi-target pharmacological characteristics of anatabine, comprehensively collates its preclinical efficacy across multiple disease categories, and highlights its advantages over nicotine in safety and addiction risk. Furthermore, we analyze the current limitations, druggability optimization challenges, and clinical translation prospects, and propose sustainable strategies for high-value utilization of tobacco byproducts. This review provides an updated and systematic theoretical basis for further mechanism exploration and therapeutic development of anatabine.<\/jats:p>","DOI":"10.3389\/ebm.2026.11069","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:10:07Z","timestamp":1782709807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in research on pharmacological mechanisms of anatabine: from nicotinic modulation to multitarget therapeutic potential"],"prefix":"10.3389","volume":"251","author":[{"given":"Xiaonan","family":"Li","sequence":"first","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaquan","family":"Sheng","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fei","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Gao","sequence":"additional","affiliation":[{"name":"Basic Research Department, Shanghai New Tobacco Product Research Institute Co., Ltd. (SNTPRI)","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10725-023-01106-w","article-title":"Tobacco as green bioreactor for therapeutic protein production: latest breakthroughs and optimization strategies","volume":"103","author":"Naeem","year":"2024","journal-title":"Plant Growth Regul"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1073\/pnas.0600879103","article-title":"An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes","volume":"103","author":"Bakker","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","volume-title":"Studies on Enzymatic Hydrolysis and Maillard Reaction with Tobacco Waste for Tobacco Flavoring","author":"Caihong","year":"2016"},{"key":"B4","doi-asserted-by":"publisher","first-page":"112191","DOI":"10.1016\/j.biopha.2021.112191","article-title":"Current advances of functional phytochemicals in nicotiana plant and related potential value of tobacco processing waste: a review","volume":"143","author":"Zou","year":"2021","journal-title":"Biomed and Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104593","DOI":"10.1016\/j.supflu.2019.104593","article-title":"Separation of active compounds from tobacco waste using subcritical water extraction","volume":"153","author":"Joki\u0107","year":"2019","journal-title":"The J Supercrit Fluids"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108256","DOI":"10.1016\/j.neuropharm.2020.108256","article-title":"Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction","volume":"177","author":"Wittenberg","year":"2020","journal-title":"Neuropharmacology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2174\/1570159X15666170818102108","article-title":"New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: a focus on \u03b17 nAChRs","volume":"16","author":"Bagdas","year":"2018","journal-title":"Curr Neuropharmacology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"106790","DOI":"10.1016\/j.phrs.2023.106790","article-title":"Autoimmunity to neuronal nicotinic acetylcholine receptors","volume":"192","author":"Pechlivanidou","year":"2023","journal-title":"Pharmacol Research"},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-443-19088-9.00004-4","article-title":"Nicotinic acetylcholine receptors in the brain","volume":"211","author":"Barrantes","year":"2025","journal-title":"Handbook Clinical Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-319-13665-3_6","article-title":"Nicotinic receptors, memory, and hippocampus","volume":"23","author":"Kutlu","year":"2015","journal-title":"Curr Topics Behavioral Neurosciences"},{"key":"B11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/15563650903252186","article-title":"Nicotinic plant poisoning","volume":"47","author":"Schep","year":"2009","journal-title":"Clin Toxicology (Philadelphia, Pa)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"109596","DOI":"10.1016\/j.drugalcdep.2022.109596","article-title":"A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation","volume":"239","author":"Jones","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0378-4274(99)00070-3","article-title":"Evidence that nicotine acetylcholine receptors are not the main targets of cotinine toxicity","volume":"109","author":"Riah","year":"1999","journal-title":"Toxicol Letters"},{"key":"B14","doi-asserted-by":"publisher","first-page":"758252","DOI":"10.3389\/fnbeh.2021.758252","article-title":"Cotinine: pharmacologically active metabolite of nicotine and neural mechanisms for its actions","volume":"15","author":"Tan","year":"2021","journal-title":"Front Behavioral Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0031-9422(00)80751-7","article-title":"The alkaloid contents of sixty nicotiana species","volume":"24","author":"Saitoh","year":"1985","journal-title":"Phytochemistry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.aca.2006.01.002","article-title":"Determination of tobacco alkaloids by gas chromatography\u2013mass spectrometry using cloud point extraction as a preconcentration step","volume":"561","author":"Shen","year":"2006","journal-title":"Analytica Chim Acta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1037\/a0035749","article-title":"Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in Male rodents","volume":"22","author":"Caine","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3389\/fphar.2023.1279512","article-title":"Pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"110723","DOI":"10.1016\/j.pnpbp.2023.110723","article-title":"Nicotine's effect on cognition, a friend or foe?","volume":"124","author":"Wang","year":"2023","journal-title":"Prog Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3969\/j.issn.1002-266X.2021.20.023","article-title":"Advances in the pharmacological mechanism of action of nicotine and its application in the treatment of neurological diseases","volume":"61","author":"Lu","year":"2021","journal-title":"Shandong Pharmaceuticals"},{"key":"B21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12640-018-9931-1","article-title":"Nicotine-induced neuroprotection in rotenone in vivo and in vitro models of parkinson\u2019s disease: evidences for the involvement of the labile iron pool level as the underlying mechanism","volume":"35","author":"Mouhape","year":"2019","journal-title":"Neurotoxicity Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0035409","article-title":"Anatabine significantly decreases nicotine self-administration","volume":"22","author":"Mello","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.drugalcdep.2015.06.005","article-title":"Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats","volume":"153","author":"Harris","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"B24","doi-asserted-by":"publisher","first-page":"111280","DOI":"10.1016\/j.drugalcdep.2024.111280","article-title":"Reinforcing and adverse observable effects of nicotine and minor tobacco alkaloids in squirrel monkeys","volume":"258","author":"Burke","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"key":"B25","doi-asserted-by":"publisher","first-page":"173223","DOI":"10.1016\/j.pbb.2021.173223","article-title":"Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish","volume":"207","author":"Hawkey","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet(London, England)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in alzheimer's disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"24573","DOI":"10.1074\/jbc.M111.333054","article-title":"Nuclear factor-\u03baB regulates \u03b2APP and \u03b2- and \u03b3-secretases differently at physiological and supraphysiological A\u03b2 concentrations","volume":"287","author":"Chami","year":"2012","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"J Int Neuropsychol Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of alzheimer\u2019s disease","volume":"24","author":"Rostagno","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13578-022-00807-5","article-title":"\u03b2-amyloid protein induces mitophagy-dependent ferroptosis through the CD36\/PINK\/PARKIN pathway leading to blood\u2013brain barrier destruction in Alzheimer\u2019s disease","volume":"12","author":"Li","year":"2022","journal-title":"Cell and Biosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1750-3639.2004.tb00087.x","article-title":"Amyloid \u03b2-Peptide(1-42) contributes to the oxidative stress and neurodegeneration found in alzheimer disease brain","volume":"14","author":"Butterfield","year":"2004","journal-title":"Brain Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2017.01.020","article-title":"Markers of neuroinflammation associated with Alzheimer\u2019s disease pathology in older adults","volume":"62","author":"Popp","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0128224","DOI":"10.1371\/journal.pone.0128224","article-title":"Chronic anatabine treatment reduces alzheimer's disease (AD)-like pathology and improves socio-behavioral deficits in a transgenic mouse model of AD","volume":"10","author":"Verma","year":"2015","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ejphar.2011.09.019","article-title":"Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo","volume":"670","author":"Paris","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.7150\/ijbs.90982","article-title":"Polyphenols targeting NF-\u03baB pathway in neurological disorders: what we know So far?","volume":"20","author":"Mamun","year":"2024","journal-title":"Int Journal Biological Sciences"},{"key":"B37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer\u2019s disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"B38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2174\/1381612826666201118092422","article-title":"Anti-neuroinflammatory potential of polyphenols by inhibiting NF-\u03baB to halt alzheimer's disease","volume":"27","author":"Md. Sahab","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B39","doi-asserted-by":"publisher","first-page":"12866","DOI":"10.1039\/D5RA00709G","article-title":"Tripeptides inhibit dual targets AChE and BACE-1: a computational study","volume":"15","author":"Do","year":"2025","journal-title":"RSC Advances"},{"key":"B40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11011-025-01615-9","article-title":"Neuroprotective potential of hispidulin and diosmin: a review of molecular mechanisms","volume":"40","author":"Singh","year":"2025","journal-title":"Metab Brain Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1567205020666230612155953","article-title":"BACE-1 inhibitors targeting alzheimer's disease","volume":"20","author":"Monteiro","year":"2023","journal-title":"Curr Alzheimer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-Secretase BACE1 in alzheimer\u2019s disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3969\/j.issn.1672-6081.2021.12.004","article-title":"Global patent intelligence study on anti-alzheimer's chemical drugs","volume":"18","author":"Shu","year":"2021","journal-title":"China Inventions and Patents"},{"key":"B44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/md19050251","article-title":"Anti-Alzheimer's molecules derived from marine life: understanding molecular mechanisms and therapeutic potential","volume":"19","author":"Kabir","year":"2021","journal-title":"Mar Drugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/md18020106","article-title":"A pharmacological comparison of two isomeric nicotinic receptor agonists: the marine toxin isoanatabine and the tobacco alkaloid anatabine","volume":"18","author":"Xing","year":"2020","journal-title":"Mar Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1239009","DOI":"10.3389\/fnins.2023.1239009","article-title":"Nicotine-mediated effects in neuronal and mouse models of synucleinopathy","volume":"17","author":"Fares","year":"2023","journal-title":"Front Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1083\/jcb.107.4.1449","article-title":"Tau proteins: the molecular structure and mode of binding on microtubules","volume":"107","author":"Hirokawa","year":"1988","journal-title":"The J Cell Biology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","article-title":"Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies","volume":"13","author":"Zhang","year":"2024","journal-title":"Translational Neurodegeneration"},{"key":"B49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Tau-mediated Neurodegeneration Alzheimer's Disease Related Disorders"},{"key":"B50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on tau protein phosphorylation in alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr Opin Neurobiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J Biol Macromolecules"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (Tau) in alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2168-975X.1000126","article-title":"Anatabine attenuates tau phosphorylation and oligomerization in P301S tau transgenic mice","volume":"3","author":"Paris","year":"2014","journal-title":"Brain Disord and Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/026988110401800403","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"J Psychopharmacology (Oxford, England)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1196\/annals.1441.016","article-title":"ADHD and smoking: from genes to brain to behavior","volume":"1141","author":"McClernon","year":"2008","journal-title":"Ann New York Acad Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11065-007-9035-9","article-title":"The effects of tobacco smoke and nicotine on cognition and the brain","volume":"17","author":"Swan","year":"2007","journal-title":"Neuropsychol Review"},{"key":"B57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10571-005-3968-4","article-title":"Nicotinic agonists, antagonists, and modulators from natural sources","volume":"25","author":"Daly","year":"2005","journal-title":"Cell and Mol Neurobiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"668065","DOI":"10.3389\/fphar.2022.668065","article-title":"Differentiating the neuropharmacological properties of nicotinic acetylcholine receptor-activating alkaloids","volume":"13","author":"Alijevic","year":"2022","journal-title":"Front Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt234","article-title":"Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel","volume":"6","author":"Stein","year":"2014","journal-title":"Alzheimer's Res and Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00304630","article-title":"Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and alzheimer's disease cases","volume":"85","author":"Hof","year":"1992","journal-title":"Acta Neuropathol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1038\/s41598-021-87161-7","article-title":"A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice","volume":"11","author":"Morin","year":"2021","journal-title":"Scientific Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/0269881114543721","article-title":"Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats","volume":"28","author":"Levin","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1017\/S1461145709000273","article-title":"The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats","volume":"12","author":"Clemens","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1038\/s41598-021-89245-w","article-title":"Differential effects of alkaloids on memory in rodents","volume":"11","author":"Callahan","year":"2021","journal-title":"Scientific Reports"},{"key":"B65","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/ntr\/ntu194","article-title":"Determination of behaviorally effective tobacco constituent doses in rats","volume":"17","author":"Wiley","year":"2014","journal-title":"Nicotine and Tob Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-8549-4_5","article-title":"Markers of inflammation","volume":"1803","author":"Germolec","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/454427a","article-title":"Inflammation","volume":"454","author":"Weiss","year":"2008","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","article-title":"Signaling pathways in inflammation and anti-inflammatory therapies","volume":"24","author":"Yeung","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B69","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/00365519409088578","article-title":"The monitoring of inflammation by specific cellular markers","volume":"219","author":"Venge","year":"1994","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00216-008-2561-3","article-title":"Inflammation markers in point-of-care testing (POCT)","volume":"393","author":"Pf\u00e4fflin","year":"2009","journal-title":"Anal Bioanal Chem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4137\/CMAMD.S13001","article-title":"Effects of dietary supplementation with the Solanaceae plant alkaloid anatabine on joint pain and stiffness: results from an internet-based survey study","volume":"6","author":"Lanier","year":"2013","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"B73","doi-asserted-by":"publisher","first-page":"639716","DOI":"10.3389\/fphar.2021.639716","article-title":"Development of an advanced multicellular intestinal model for assessing immunomodulatory properties of anti-inflammatory compounds","volume":"12","author":"Marescotti","year":"2021","journal-title":"Front Pharmacology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12950-020-00260-6","article-title":"Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis","volume":"17","author":"Ruiz Castro","year":"2020","journal-title":"J Inflamm"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/exd.14192","article-title":"Impact of cigarette smoke on physical\u2010chemical and molecular proprieties of human skin in an ex vivo model","volume":"30","author":"Percoco","year":"2021","journal-title":"Exp Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3390\/ijms24076419","article-title":"Tobacco alkaloid assessment in a DSS-induced colitis mouse model with a fully humanized immune system","volume":"24","author":"Verhaeghe","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/biomedicines11030922","article-title":"Nicotine exerts a stronger immunosuppressive effect than its structural analogs and regulates experimental colitis in rats","volume":"11","author":"Okada","year":"2023","journal-title":"Biomedicines"},{"key":"B78","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2012.11.017","article-title":"Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation","volume":"698","author":"Paris","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1021\/acs.jnatprod.0c01044","article-title":"In vivo profiling of a natural alkaloid, anatabine, in rodents: Pharmacokinetics and anti-inflammatory efficacy","volume":"84","author":"Xia","year":"2021","journal-title":"J Nat Prod"},{"key":"B80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment","volume":"22","author":"van","year":"2021","journal-title":"Am Journal Clinical Dermatology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: pathogenesis and therapeutic correlates","volume":"28","author":"Geng","year":"2024","journal-title":"J Cutaneous Medicine Surgery"},{"key":"B82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2019.01.018","article-title":"Nuclear factor Kappa-B is enriched in eyelid specimens of rosacea: implications for pathogenesis and therapy","volume":"201","author":"Wladis","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1159\/000357019","article-title":"Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study","volume":"5","author":"Lanier","year":"2013","journal-title":"Case Rep Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care and Research"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.bone.2006.05.016","article-title":"Factors affecting the prevalence of osteoarthritis in healthy middle-aged women: data from the longitudinal Melbourne Women's midlife health project","volume":"39","author":"Szoeke","year":"2006","journal-title":"Bone"},{"key":"B86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1550-2783-10-33","article-title":"The effects of anatabine on non-invasive indicators of muscle damage: a randomized, double-blind, placebo-controlled, crossover study","volume":"10","author":"Jenkins","year":"2013","journal-title":"J Int Soc Sports Nutr"},{"key":"B87","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejphar.2014.01.054","article-title":"Effects of anatabine and unilateral maximal eccentric isokinetic muscle actions on serum markers of muscle damage and inflammation","volume":"728","author":"Jenkins","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.ackd.2019.03.001","article-title":"Inflammation, immunity, and oxidative stress in hypertension\u2014partners in crime?","volume":"26","author":"Barrows","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jcp.31019","article-title":"Inflammation and hypertension: underlying mechanisms and emerging understandings","volume":"238","author":"Aboukhater","year":"2023","journal-title":"J Cell Physiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s12012-025-10034-2","article-title":"Chronic anatabine administration attenuates cardiovascular activity by targeting NF-\u03baB\/NLRP3\/Caspase-1-Dependent pyroptosis and oxidative stress in paraventricular nucleus of hypertensive rat","volume":"25","author":"Su","year":"2025","journal-title":"Cardiovasc Toxicol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/alr.21609","article-title":"Asthma: definitions and pathophysiology","volume":"5","author":"Mims","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"120954","DOI":"10.1016\/j.lfs.2022.120954","article-title":"Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2\/HO-1 signaling upregulation in rats","volume":"308","author":"Abdo","year":"2022","journal-title":"Life Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/iid3.490","article-title":"Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK\/Sirt1 and Nrf2\/HO-1 pathways","volume":"9","author":"Xu","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3389\/fphar.2022.1011184","article-title":"Systems biology reveals anatabine to be an NRF2 activator","volume":"13","author":"Messinis","year":"2022","journal-title":"Front Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.1210\/jc.2013-2951","article-title":"Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial","volume":"99","author":"Schmeltz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1210\/en.2012-1452","article-title":"Anatabine ameliorates experimental autoimmune thyroiditis","volume":"153","author":"Caturegli","year":"2012","journal-title":"Endocrinology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00018-010-0525-1","article-title":"Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases","volume":"68","author":"Bencherif","year":"2011","journal-title":"Cell Molecular Life Sciences : CMLS"},{"key":"B98","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1124\/mol.110.066381","article-title":"\u03b14\u03b22 nicotinic receptors partially mediate anti-inflammatory effects through janus kinase 2-signal transducer and activator of transcription 3 but not calcium or cAMP signaling","volume":"79","author":"Hosur","year":"2011","journal-title":"Mol Pharmacology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","article-title":"Cholinergic control of inflammation","volume":"265","author":"Rosas-Ballina","year":"2010","journal-title":"J Intern Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"112187","DOI":"10.1016\/j.phytochem.2019.112187","article-title":"An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human \u03b14\u03b22 and \u03b17 nicotinic acetylcholine receptors","volume":"170","author":"Alijevic","year":"2020","journal-title":"Phytochemistry"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2026.11069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:10:10Z","timestamp":1782709810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2026.11069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":100,"alternative-id":["10.3389\/ebm.2026.11069"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2026.11069","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"11069"}}